GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » Equity-to-Asset

Mangoceuticals (Mangoceuticals) Equity-to-Asset : -3.18 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Mangoceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-0.96 Mil. Mangoceuticals's Total Assets for the quarter that ended in Mar. 2024 was $0.30 Mil. Therefore, Mangoceuticals's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was -3.18.

The historical rank and industry rank for Mangoceuticals's Equity-to-Asset or its related term are showing as below:

MGRX' s Equity-to-Asset Range Over the Past 10 Years
Min: -3.18   Med: 0.79   Max: 0.93
Current: -3.18

During the past 3 years, the highest Equity to Asset Ratio of Mangoceuticals was 0.93. The lowest was -3.18. And the median was 0.79.

MGRX's Equity-to-Asset is ranked worse than
96.47% of 680 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs MGRX: -3.18

Mangoceuticals Equity-to-Asset Historical Data

The historical data trend for Mangoceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals Equity-to-Asset Chart

Mangoceuticals Annual Data
Trend Dec21 Dec22 Dec23
Equity-to-Asset
-0.74 0.61 0.74

Mangoceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 0.91 0.85 0.74 -3.18

Competitive Comparison of Mangoceuticals's Equity-to-Asset

For the Health Information Services subindustry, Mangoceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mangoceuticals's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mangoceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Mangoceuticals's Equity-to-Asset falls into.



Mangoceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Mangoceuticals's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0.775/1.051
=0.74

Mangoceuticals's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=-0.958/0.301
=-3.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangoceuticals  (NAS:MGRX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Mangoceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangoceuticals (Mangoceuticals) Business Description

Traded in Other Exchanges
N/A
Address
15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.
Executives
Amanda Elizabeth Hammer officer: Chief Operating Officer 5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen director, 10 percent owner, officer: CEO 2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust 10 percent owner 19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers director 5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio director 8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston officer: CFO PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango director, officer: President, COO and Secretary 15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248
Alex P. Hamilton director 26 LOOP ROAD, BEDFORD NY 10506